By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular in a deal valued at $550 million, expanding its line-up of products used ...

Medtronic plc (NYSE:MDT) is included among the 14 Quality Stocks with Highest Dividends. On March 10, Medtronic plc (NYSE:MDT ...

Medtronic strengthens neurovascular segment with advanced guidewire technologies; Scientia Vascular enhances complex stroke procedure device capabilities globally; Bro ...

Merit Medical Systems (NasdaqGS:MMSI) has entered a new distribution agreement with Medtronic covering the FDA cleared ViaVerte basivertebral nerve ablation system. The expanded partnership focuses on ...

Medical device company Medtronic plc. (NYSE:MDT) recently revealed that it has entered into a definitive agreement to acquire Affera, a medical technology company. The financial terms of the deal have ...

Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...

Medtronic plc reported Q2 earnings today, with revenues of $8.4bn, up 5% year-on-year, adjusted EPS of $1.26, supported by a dividend yielding 3.2%. Despite consistent mid-single-digit revenue growth ...

An extensive review of a much-scrutinized Medtronic, Inc., “bone-growth” product found that the product provides little to no benefits over more typical treatments. Fridley-based Medtronic, the ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...

Medtronic has pulled one of its most controversial products, Infuse Bone Graft, off the market in Australia as regulators there investigate why the company was widely selling it without a required ...